Advancing Safe, Comprehensive, Digitally-Enabled Cancer Pain Management (ASCENT) Clinical Trial - Main
This clinical trial tests a collaborative pain management intervention (ASCENT) for improving cancer pain in cancer survivors. Cancer pain is prevalent, under-treated, and remains a major cause of suffering, impairment, and disability for millions of Americans. Individual pain interventions and care models show promise for cancer pain in controlled settings. All cancer survivors stand to benefit from electronic health record innovations, as they can experience profound pain outcomes, including marked under- and over-prescribing of opioids. Digitally facilitated solutions are especially helpful and can be customized to address patient needs. The ASCENT intervention provides patients with an educational guide that describes techniques for addressing cancer pain, and uses community health workers and pain care managers to coach patients through a personalized pain management plan. This study may help researchers learn how pain management strategies can improve cancer pain and lower risk of opioid exposure and dependency in cancer survivors.
• A qualifying liquid or solid cancer diagnosis with visits at a participating Mayo site in the past 15 years
⁃ Including malignant hematology
∙ Lymphoma
‣ Myeloma
‣ Chronic leukemias
• Age \>= 18
• Numeric Rating Scale (NRS) pain score of \>= 5/10
• Pain that developed or worsened following cancer diagnosis
• Fit the description of either rural or Hispanic or both